Ontario Brain Institute announces $600,000 in funding to the NERVE cohort

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

The Ontario Brain Institute recently announced $600,000 in funding to the 2023 NERVE cohort, a group of six entrepreneurs funded through Canada's single largest award for early-stage neurotechnology companies. The Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE) program provides $100,000 to awarded Canadian-based entrepreneurs, in addition to 12 months of training and mentorship opportunities.

Congratulations to the NERVE cohort and special shout-out to OBIO® member, Foqus Technologies, that is also a part of our current CAAP® cohort.

Arsheen Kaur
Previous

Paradox Immunotherapeutics is BIO’s emerging Start-Up Stadium winner
Next

OBIO® opens applications for its newly-launched Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence